Oscar Health Inc (OSCR)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $9.65B
Last updated: Nov 17, 2026 at 4:43 PM ET
Oscar Health Inc (OSCR) Statistics
Oscar Health (OSCR) has a market cap of $9.65B and an enterprise value of $5.61B. Its share count is up 19.31% from a year earlier. Revenue grew 54.77% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 41.82% below the market cap, as cash exceeds debt.
| Market Cap | $9.65B |
|---|---|
| Enterprise Value | $5.61B |
| Latest price (Nov 17, 2026) | $29.84 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.5x and 4.2x.
| P/E Ratio | 12.3x |
|---|---|
| Forward P/E | 14.1x |
| P/S Ratio | 0.5x |
| Forward P/S | 0.5x |
| P/B Ratio | 4.2x |
| P/FCF Ratio | 2.2x |
| P/OCF Ratio | 2.3x |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.6x EBITDA and 1.3x free cash flow.
| EV / Earnings | 6.6x |
|---|---|
| EV / Sales | 0.3x |
| EV / EBITDA | 5.6x |
| EV / EBIT | 6.1x |
| EV / FCF | 1.3x |
Price Statistics
The stock is up 115.02% over 52 weeks and trades 6.52% below its 50-day average.
| Beta (1Y) | 1.38 |
|---|---|
| 52-Week Change | +115.02% |
| 1-Month Change | -8.28% |
| 3-Month Change | -7.60% |
| 6-Month Change | +21.72% |
| 5-Year Change | +75.75% |
| Total Return (1Y) | +115.02% |
| Total Return (3Y CAGR) | +57.68% |
| Total Return (5Y CAGR) | +22.93% |
| Return vs SPY (1Y) | +91.33% |
| Max Drawdown (1Y) | -40.25% |
| Max Drawdown (3Y) | -53.39% |
| Sharpe Ratio (1Y) | 1.11 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $31.92 |
| 200-Day Average | $24.60 |
| 52-Week Range | $10.69 to $38.50 |
| RSI (14 Days) | 42.5 |
| Average Volume (20 Days) | 5.44M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.14x current liabilities, and total debt is 0.19x shareholder equity.
| Current Ratio | 1.14x |
|---|---|
| Quick Ratio | 1.14x |
| Debt / Equity | 0.19x |
| Debt / EBITDA | 0.47x |
| Debt / FCF | 0.10x |
| Interest Coverage | 66.92x |
Returns and Efficiency
Return on invested capital is 32.72% over the last 12 months, against a 5-year average of -29.81%.
| Return on Equity (ROE) | 38.50% |
|---|---|
| Return on Assets (ROA) | 8.55% |
| Return on Invested Capital (ROIC) | 32.72% |
| Return on Capital Employed (ROCE) | 33.91% |
| ROE (5Y Average) | -37.21% |
| ROA (5Y Average) | -8.93% |
| ROIC (5Y Average) | -29.81% |
| Asset Turnover | 2.22x |
| Receivables Turnover | 51.14x |
Taxes
Income tax took 5.39% of pretax income over the last 12 months.
| Income Tax (TTM) | $48.76M |
|---|---|
| Effective Tax Rate | 5.39% |
Scores
OSCR has an Altman Z-Score of 2.59, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.59 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $17.47B over the last 12 months.
| Revenue | $17.47B |
|---|---|
| Revenue Growth (YoY) | +54.77% |
| Gross Profit | $13.61B |
| Operating Income | $936.99M |
| Pretax Income | $904.48M |
| Net Income | $855.72M |
| EBIT | $918.21M |
| Reported EPS (TTM) | $2.42 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 22.18% of the $10.01B in total assets.
| Cash and Equivalents | $4.47B |
|---|---|
| Total Debt | $432.41M |
| Net Cash | $4.03B |
| Net Cash Per Share | $13.04 |
| Working Capital | $1.01B |
| Shareholder Equity | $2.22B |
| Book Value Per Share | $7.19 |
| Total Assets | $10.01B |
| Total Liabilities | $7.78B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $40.93M of capital spending, operating cash flow left $4.14B of free cash flow.
| Operating Cash Flow | $4.18B |
|---|---|
| Capital Expenditures | $40.93M |
| Free Cash Flow | $4.14B |
| FCF Per Share | $15.15 |
| Depreciation and Amortization | $52.98M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 5.36%, against a 5-year average of -10.26%.
| Gross Margin | 77.92% |
|---|---|
| Operating Margin | 5.36% |
| Pretax Margin | 5.18% |
| Net Margin | 4.90% |
| EBIT Margin | 5.26% |
| FCF Margin | 23.70% |
| Gross Margin (5Y Average) | 65.78% |
| Operating Margin (5Y Average) | -10.26% |
| Net Margin (5Y Average) | -10.91% |
Growth
Revenue grew 43.45% a year over 3 years.
| Revenue Growth (3Y CAGR) | +43.45% |
|---|---|
| Revenue Growth (5Y CAGR) | +90.80% |
| FCF Growth (3Y CAGR) | +44.43% |
| FCF Growth (5Y CAGR) | +38.37% |
| Book Value Per Share Growth (2Y CAGR) | -1.26% |
| Tangible Book Per Share Growth (2Y CAGR) | -1.26% |
Dividends and Yields
OSCR does not pay a dividend. Its free cash flow yield is 44.86%.
| Earnings Yield | 8.13% |
|---|---|
| FCF Yield | 44.86% |
| Shareholder Yield | 0.00% |
Peer Position
Against 12 similar companies, OSCR has the 10th highest P/E and the 7th highest P/S.
P/E RatioPeer median 22.1x
P/S RatioPeer median 0.5x
ROICPeer median 8.35%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.39%
| P/E Ratio | 12.3x vs 22.1x median |
|---|---|
| P/S Ratio | 0.5x vs 0.5x median |
| ROIC | 32.72% vs 8.35% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +54.77% vs +7.39% median |
Analyst Forecast
Consensus estimates put revenue growth at 34.27% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +34.27% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OSCR
What is OSCR's market cap?
Oscar Health has a market cap of $9.65B. Its enterprise value, which adds debt and subtracts cash, is $5.61B.
What is OSCR's P/E ratio?
Oscar Health has a trailing P/E ratio of 12.3x and a forward P/E of 14.1x.
How many shares of OSCR are outstanding?
Oscar Health has 309.34M shares outstanding. The count is up 19.31% from a year earlier.
Does OSCR pay a dividend?
No. Oscar Health does not pay a dividend.
How much debt does OSCR have?
Oscar Health has $432.41M of total debt and $4.47B of cash and equivalents, a net cash position of $4.03B.
OSCR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors